Development of an HPLC Method for the Determination of Meropenem/Vaborbactam in Biological and Aqueous Matrixes.

J Chromatogr Sci

Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, CT, USA.

Published: August 2020

A HPLC method was developed and validated to analyze meropenem and vaborbactam simultaneously in murine plasma and saline matrixes. A 60-μL volume of extracted sample was injected onto a 5-μm BDS Phenyl-Hypersil C18 reversed-phase column and analyzed with a UV detector set at 298 nm for the first 4.9 min and switched to 240 nm. The mobile phase contained a mixture of methanol and 25-mM sodium phosphate buffer set at a flow rate of 1.0 mL/min for the 16 min run time. Cefuroxime was used as the internal standard. The standard curves were linear over a range of 0.25-50 μg/mL. The precision and accuracy for 0.25 μg/mL (LLQ) in plasma for both compounds were <4.8% and >98.9%, respectively. Interday and intraday precision and accuracy for all QC plasma samples for both compounds were <6.2% and >95.7%, respectively. This methodology details a reproducible assay for both compounds using a single extraction with good accuracy and precision.

Download full-text PDF

Source
http://dx.doi.org/10.1093/chromsci/bmaa041DOI Listing

Publication Analysis

Top Keywords

hplc method
8
precision accuracy
8
development hplc
4
method determination
4
determination meropenem/vaborbactam
4
meropenem/vaborbactam biological
4
biological aqueous
4
aqueous matrixes
4
matrixes hplc
4
method developed
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!